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ABSTRACT 
Radiotherapy cures patients from deadly cancer, alone or in 
combination with other treatments. The photons must pass through 
normal tissue to converge on the tumor, and it is unavoidable that 
radiotherapy causes acute side effects as well as late adverse effects. 
Roughly one million cancer survivors in Europe are suffering from 
radiation-induced intestinal symptoms, such as urgency to defecate, 
leakage of feces and mucus, bleeding, and excessive odorous gas 
discharge. The symptoms can appear in the pelvic-organ cancer 
survivor weeks to years after the treatment and severely reduce the 
quality of life. Very little is known about how radiation-induced 
pathological processes progress over time and how various factors 
such as diet influence the disease course. One reason is the lack of 
preclinical models that allow for a long-term follow-up after 
irradiation. To better understand the dynamics of intestinal injury after 
radiotherapy, we have developed a novel model of pelvic radiotherapy 
and determined the injury and repair mechanisms over time. In the 
study for Paper I, we used the clinic's linear accelerator to irradiate a 
small field limited to the murine colorectum. The use of the clinic’s 
linear accelerator protected overall animal health and ensured their 
 long-term survival. We found that the pathophysiology after 4 
fractions of 8 Gy was similar to what is seen in biopsies of pelvic-
organ cancer survivors, and that crypt degeneration was fraction-
dependent and still ongoing at six weeks post-irradiation. Moreover, 
there was an increased number of macrophages in the mucosa at six 
weeks, possibly reflecting a lasting inflammatory activity. In the study 
for Paper II, we characterized the mouse model over a period of 30 
weeks. We observed that crypt degeneration was still present at 30 
weeks post-irradiation, as well as an increased presence of 
macrophages, possibly reflecting a chronic, low-grade inflammation. 
We also found that crypt fission, not cell proliferation, was the main 
repair mechanism after one week post-irradiation and onwards. In 
Papers III & IV, we studied the effect of bioprocessed oat bran, rich 
in dietary fiber, on radiation-induced damage to the intestine. In Paper 
III, we observed that the intake of dietary fiber modified the onset, 
timing, and intensity of radiation-induced pathophysiological processes 
when compared to a fiber-free diet. In the study for Paper IV, we 
observed that irradiation resulted in a long-lasting increase of serum 
cytokines indicating a chronic low-grade inflammation and that a fiber-
free diet worsened this pro-inflammatory serum profile. In 
convergence, pelvic irradiation results in long-lasting, possibly 
chronic, pathophysiological changes in the intestines that may be 
driven by underlying low-grade inflammation. Nevertheless, even long 
after irradiation, the intestine attempts to repair itself via crypt fission. 
This mechanism as well as dietary interventions has the potential to 
modify the progression of the disease and may be explored further. 
Keywords: pelvic radiotherapy, intestinal inflammation, crypt fission, 
dietary fiber. 
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SAMMANFATTNING PÅ SVENSKA 
Strålbehandling används för att behandla patienter med malignitet i 
bäckenområdet, men åtföljs av både akuta biverkningar och 
seneffekter. Uppskattningsvis en miljon canceröverlevare i Europa 
lider av strålningsinducerade tarmbesvär, såsom trängningssyndrom, 
läckage av avföring och slem, blödningar och illaluktande gaser. 
Symtomen kan uppträda år till decennier efter avslutad behandling, 
och minskar ofta canceröverlevarens livskvalité drastiskt. Ändå är 
mycket lite känt om hur strålningsinducerade patologiska processer 
utvecklas över tid och hur olika faktorer såsom kost påverkar 
sjukdomsförloppet. En anledning är bristen på prekliniska modeller 
som möjliggör långtidsuppföljning efter bestrålning. För att bättre 
förstå de underliggande sjukdomsprocesserna har vi utvecklat en ny 
modell för bäckencancerstrålning och fastställt skade- och 
reparationsprocesser över tid. I Artikel I använde vi klinikens 
linjäraccelerator för att bestråla ett litet fält begränsat till kolorektum 
hos mus. Genom att använda oss av linjära acceleratorns lilla strålfält 
bibehölls mössens generella hälsa och de kunde studeras över lång tid. 
Vi fann att patofysiologin efter 4 fraktioner av 8 Gy liknade den som 
ses i biopsier från bäckencanceröverlevare. Den strålningsinducerade 
kryptdegenerationen var beroende av antalet fraktioner och pågick 
fortfarande sex veckor efter bestrålning. Dessutom fanns ett ökat antal 
makrofager i slemhinnan vid sex veckor, vilket indikerade en varaktig 
inflammatorisk aktivitet. I Artikel II följde vi skade- och 
reparationsprocesser under en period av 30 veckor. Vi observerade att 
kryptdegenerationen fortfarande pågick 30 veckor efter bestrålning, 
liksom den ökade förekomsten av makrofager, vilket möjligen 
återspeglade en kronisk, låggradig inflammation. Vi fann också att 
kryptfission, inte cellproliferation, var den viktigaste 
reparationsmekanismen en vecka efter bestrålning och framåt. I Artikel 
III & IV studerade vi effekten av fiberrikt bioprocessat havrekli på 
strålningsinducerad skada på tarmen. I artikel III observerade vi att 
intaget av kostfiber modifierade debuten, varaktigheten och 
 intensiteten hos strålningsinducerade patofysiologiska processer 
jämfört med en fiberfri diet. I artikel IV observerade vi att bestrålning 
resulterade i en långvarig ökning av serumcytokiner som indikerade en 
kronisk låggradig inflammation, och att en fiberfri diet förvärrade 
denna pro-inflammatoriska serumprofil. Sammantaget fann vi att 
bäckenstrålningen resulterade i mycket långvariga patofysiologiska 
förändringar vilka möjligen drivs av en underliggande låggradig 
inflammation. Trots det försöker tarmen, även långt efter bestrålning, 
reparera sig själv via främst kryptfission. Denna mekanism, liksom 
kostinterventioner, har potential att påverka sjukdomsförloppet.
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 INTRODUCTION 
Pelvic radiation – a widespread cause of reduced quality of life among 
cancer survivors  
Cancer has been part and parcel of the health problems faced by 
modern society. Patients suffering from cancer can be treated by many 
different methods such as surgery, radiotherapy, chemotherapy, 
hormonal therapy, or multimodal treatment (a combination of two or 
more treatments). Radiotherapy is the most common method of 
treatment and approximately 60-65 percent of cancer patients receive 
radiotherapy as a sole treatment modality or in combination with 
surgery or chemotherapy [1]. 
Radiotherapy is the use of ionizing radiation to treat cancerous tissue. 
Radiation not only kills the cancer tissue but also damages the 
surrounding healthy tissue. Exposing the pelvic area to high-energy 
particles during pelvic-organ cancer treatment leads to acute (early) 
and chronic (late) problems, where the various symptoms are 
manifestations of what is commonly referred to as Pelvic Radiation 
Disease [2, 3]. It is estimated that approximately 90 percent of the 
pelvic cancer survivors experience a permanent change in bowel 
habits. Of them, 50 percent have difficulties in performing daily 
activities, and 30 percent report moderate to severe symptoms after 
pelvic radiotherapy, reducing their quality of life [4]. The development 
and severity of radiation-induced symptoms during and after pelvic 
radiotherapy not only depend on the total dose given to the patient but 
also on other factors like radiotherapy techniques, positioning of 
devices, and life-style related factors [2, 5]. 
An acute manifestation includes looseness of the bowels, abdominal 
pain, bloating, loss of appetite, nausea, and fecal urgency. Patients 
notice acute effects normally during the second week of treatment with 
a maximum intensity at four to five weeks. Chronic effects may begin 
to develop six months to three years after pelvic radiotherapy. They 
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can even appear up to two decades after receiving the treatment [6]. A 
study by Steineck et al. identified nearly 30 symptoms in 
gynecological survivors, 2-15 years after radiotherapy and they were 
categorized into five main syndromes [7]. Signs of late effects include 
fecal urgency, uncontrolled defecation, excessive mucus discharge, 
excessive bleeding, and odorous flatulence. Moreover, bile 
malabsorption and bacterial dysbiosis may contribute to the late effects 
[8]. 
Pathophysiological processes involved in normal-tissue 
injury after irradiation 
The pathophysiological processes involved in radiation-induced 
normal tissue injury start immediately following the exposure, 
although not all of the histological changes may become apparent until 
weeks or months after treatment. Some of the problems related to 
normal tissue injury after radiation include oxidative stress, vascular 
damage, fibrosis, inflammation that alters the intestinal 
microenvironment, and disruption of the stem cell niche [9].  
The intestinal epithelium is a single-layered and rapidly self-renewing 
tissue [10]. Regeneration of the epithelium after an injury is dependent 
on the stem cells present at the base of the crypt [11, 12]. When the 
dividing stem cells are exposed to ionizing radiation, it directly hits 
DNA and breaks the bond between the base pairs of the DNA in the 
cell nuclei and also indirectly through the generation of free radicals 
that react with the DNA, which leads to structural damage and cell 
apoptosis. The loss of stem cells is believed to cause the crypts to 
degenerate and eventually being replaced by fibrotic tissue [13]. 
Several radiation-induced mechanisms such as hypoxia, vascular 
injury, loss of tight junctions, and loss of gut wall integrity may further 
enhance crypt degeneration [14].  
The microbiota appears to play a role in the development of the acute 
and chronic effects following the radiation. In normal conditions, the 
epithelial barrier is impermeable for the bacteria. Radiation to the 
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epithelium disrupts the tight junctions of the gut wall, thereby 
increasing the permeability and allowing a bacterial inflow from the 
lumen. Radiation-induced apoptosis also leads to disruption of the 
barrier. This may cause inflammation, which in turn affects the 
regeneration of the epithelium [14]. A few human studies have shown 
that patients who received radiotherapy for different cancers had 
mucosal barrier dysfunction [15, 16]. Rodent studies showed an 
increased passage of tracers in the extracellular spaces in ileum after 
irradiation [17, 18]. Furthermore, a study in mice showed that 
epithelial barrier dysfunction causes an increase in permeability, 
leading to the activation of immune cells [19].  
If the pathophysiological processes involved in acute damage are not 
resolved, then it could lead to chronic or late damage. Studies in 
rodents have shown that acute mucosal damage leads to delayed 
intestinal complications [20, 21]. These observations suggest that acute 
mucosal injury can contribute to late intestinal toxicity [22]. Several 
studies have confirmed the protective role of trophic growth factors, 
such as keratinocyte growth factor (KGF) [23, 24] and glucagon-like 
peptide-2 (GLP-2) [25] against irradiation in murine models. The 
clinical use of trophic factors faced a crucial problem in cancer patients 
related to stimulatory action on tumor growth [26, 27]. 
Radiation-induced vascular injury  
Despite the improvements in radiotherapy, damage to the intestinal 
endothelial cells remains a clinical problem. Radiation-induced 
vascular damage was initially described more than 50 years ago [28]. 
Several clinical studies demonstrated that cancer patients who received 
radiotherapy were at increased risk of developing vascular diseases 
[29, 30]. The radiation effects on vascular tissue occur in 2 waves. The 
acute effects occur immediately after the irradiation; they include 
endothelial apoptosis. Preclinical studies have also shown that stem 
cell apoptosis and depletion of microvascular endothelial cells are 
associated with acute gastrointestinal manifestations [31, 32]. 
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Radiation causes acute up-regulation of pro-inflammatory cytokines 
and adhesion molecules that recruit inflammatory cells to the site of 
vascular injury [33, 34]. In addition to the direct damage, free radicals 
produced by radiation causes oxidative stress. Oxidative stress up-
regulates the pathways related to vascular disease, including matrix 
metalloproteinases, adhesion molecules, pro-inflammatory cytokines, 
and smooth muscle cell proliferation and apoptosis, while inactivating 
vascular-protective nitric oxide [35]. A study in a transgenic mouse 
model showed that NF-kB serves as a molecular link between 
oxidative stress and chronic inflammation [36].  
Chronic vascular effects occur months after irradiation; they include 
thickening of the basement membrane, capillary loss, loss of 
clonogenic capacity and telangiectasia [37]. These late effects of the 
vascular injury may thus contribute to the progression of the intestinal 
pathophysiology after irradiation. 
Radiation-induced mucosal inflammation 
Radiation induces inflammatory responses by apoptosis, generation of 
free radicals, mucosal breakdown, and the activation of several pro-
inflammatory cytokines and chemokines [38]. The excessive 
generation of free radicals after irradiation can be considered as a pro-
inflammatory signal, subsequently affecting the innate and adaptive 
immune responses [39]. The early inflammatory response appears only 
a few hours after radiation. It is a well-regulated process that recruits 
circulating monocytes as well as the activation of resident 
macrophages. Depending on the inflammatory conditions, monocytes 
can be differentiated into M1/ pro-inflammatory and M2/ anti-
inflammatory macrophages [40, 41]. Several studies have reported that 
the infiltration of macrophages to the site of injury occurs after 
irradiation [42-44]. Macrophages are known to play a role in the 
resolution of inflammation by cleaning the debris and secreting signals 
that switch off the inflammatory response. Moreover, radiation-
induced epithelial barrier breakdown facilitates the entry of pathogens, 
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leading to activation of immune cells that could secrete pro-
inflammatory cytokines in mucosa such as IL-1, IL-8, and IL-6 [42, 
43].  
Fibrosis is an important end result of irradiation-induced injury to the 
intestine and it is described as an irreversible process that occurs under 
chronic injury conditions caused by a bacterial infection, ischemia, and 
chronic inflammation [45, 46]. Fibrosis is characterized by excessive 
accumulation of extracellular matrix (ECM), mainly deposition of 
collagen and fibronectin in and around the damaged tissue, causing 
loss of function and permanent scarring [47]. In animal experiments, 
an increased level of TGF- has been observed in intestines after 
irradiation. TGF- is known as a potent fibrogenic and promotes 
fibrosis by stimulating the expression of collagen and fibronectin.  
Repair mechanisms after radiation-induced intestinal 
injury  
The epithelium of the intestines displays an impressive regenerative 
capacity after injury. There are two major mechanisms involved in the 
regeneration of mucosa after injury; crypt stem cell proliferation and 
crypt fission.  
It is well known that Lgr5+ intestinal stem cells, also called crypt base 
columnar (CBC) cells, are the major contributors to the epithelial 
renewal in the small intestine and colon [48]. These CBC cells are very 
sensitive and are depleted upon exposure to radiotherapy or 
chemotherapy. When the CBC cells are depleted, radio-resistant 
Krt19+ reserve stem cells are activated [49]. Several studies have 
reported the role of reserve stem cells in regeneration after injury, 
although most have focused on the small intestine (reviewed in [50]).  
The effect of radiation on crypt stem cell proliferation has been 
extensively studied, at least in the early phase after irradiation, but very 
little attention has been given to the role of crypt fission. Crypt fission 
is defined as the formation of two daughter crypts from a parent crypt, 
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and it is more frequently observed during the developmental phase. In 
the human colon, a crypt will undergo crypt fission every 30 to 40 
years [51]. A few studies have proposed that crypt fission is a 
regenerative process in response to intestinal injuries, such as after 
irradiation or chemotherapy [52] and in inflammatory bowel disease 
[53]. A study by Berlanga et al. showed that crypt cell proliferation 
and crypt fission are two independent mechanisms in rodents [54]. 
However, little is known about how crypt fission is regulated.  
Role of dietary fiber 
The term dietary fiber is defined as an edible part of the plant 
consisting of polysaccharides, resistant to digestion and absorption in 
the small intestines, with partial or complete fermentation in the colon 
[55]. Dietary fiber can be categorized in many ways; most commonly 
based on solubility in water. Pectin, inulin, -glucan, gums and other 
polysaccharides are considered water-soluble dietary fibers and mostly 
act as prebiotics, whereas cellulose, lignin, and hemicellulose are 
considered water-insoluble dietary fibers, and are responsible for an 
increase in fecal bulk that affects intestinal transit [56]. 
The beneficial effect of dietary fiber on intestinal health has been 
known for a long time, and many studies have evaluated its health 
benefits [57, 58]. Today’s increased scientific interest concerning the 
role of the microbiota in health and disease has further promoted 
dietary fiber as a beneficial nutrient to include within the diet. The 
fermentation of polysaccharides, oligosaccharides and other dietary 
fiber by the colonic bacteria produces short-chain fatty acids (SCFAs) 
namely, acetate, propionate, and butyrate [59, 60]. Numerous factors 
are involved in the production rate, amount, and type of SCFAs 
produced in the colon, including substrate source, the colonic pH, the 
abundance and composition gut microbiota, and the gut transit time 
[60]. Depending on the above-mentioned factors, SCFAs can 
contribute up to 10% of the total human caloric requirement [61]. Out 
of the three most common SCFAs formed during fermentation, 
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butyrate is considered most important for the maintenance of colonic 
health [62-64].  
Butyrate is used as an energy source by colonocytes in the colon and 
also plays a major role in the regulation of cell proliferation and 
differentiation [59, 65, 66], while acetate and propionate reach the liver 
via the portal vein. SCFAs in the colon influences each other’s 
production and function [67], especially converting from acetate into 
butyrate [68]. In-vitro studies showed that the butyrate and mixture of 
acetate and propionate protect colonocytes from DNA damage induced 
by reactive oxygen species [69, 70]. 
SCFAs maintain colonic homeostasis mainly by protecting colonocytes 
and maintaining the intestinal barrier. Several studies have confirmed 
that the supplementation of SCFA improved colonic barrier function 
[71, 72]. SCFAs also protect the mucus layer by regulating the levels 
of immune modulators such as prostaglandins [73]. 
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AIMS 
The overall aim of the research leading to this PhD thesis was to 
increase the understanding of the pathophysiological processes 
involved in radiation-induced intestinal damage and to acquire 
knowledge that can be used to prevent such damage. To provide the 
means to achieve this, my research had the following four specific 
aims: 
 
Paper I: To establish a novel mouse model of radiation-induced late 
effects in the intestines. 
Paper II: To define the long-term trajectory of mucosal injury and 
repair mechanisms in the mouse model.  
Paper III: To address the hypothesis that a high-fiber diet increases 
the resiliency of the gut wall and protects from radiation-induced 
intestinal damage.  
Paper IV: To investigate whether consuming a high-fiber diet could 
reduce ongoing systemic inflammation after irradiation. 
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MATERIAL AND METHODS 
Animals 
All the experimental procedures were approved by the Gothenburg 
Ethical Committee of the Swedish Animal Welfare Agency 
(application number for the paper I, II, 22-2015 and paper III, 
IV  1458-2018). All studies were performed on male young adult 
C57BL/6J mice. 8 to 10 weeks old mice were purchased from Charles 
River Laboratories International and were maintained at a constant 
temperature of 20°C, 42 % relative humidity with a regular 12-hour 
light/ dark cycle. Animals had free access to food and water. The 
acclimatization period for the conditions was 1-2 weeks before all the 
experiments.  
Comment: Mice intestinal physiology is well characterized and similar 
to human intestinal physiology. The mouse genome has been entirely 
mapped, and mice can be genetically modified for the study of 
mechanisms on a cellular or molecular level. In our experiments, only 
male mice were used. Female mice were not used in any of the 
experiments since their reproductive organs would fall within the 
target area of the radiation. 
Experimental model 
Irradiation Procedure 
The irradiation procedure was carried out at Jubileumskliniken at the 
Sahlgrenska University Hospital in Gothenburg. To ensure that each 
mouse was in an identical position under the linear accelerator, the 
mice were kept anesthetized in a silicone mold, using a portable 
anesthesia unit connected to nose cone delivering 2.5% - 3% isoflurane 
with airflow of 300mL/min. In paper I, a linear accelerator (Varian 
Clinac 600 CD; Radiation Oncology System, San Diego, CA) with 4 
MV photon energy producing a dose-rate of 3.2 Gy/min was used. In 
paper II, III, and IV, a linear accelerator (Varian TrueBeam; Varian 
Medical Systems Inc., Charlottesville, VA, USA), with 6 MV photon 
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energy producing a dose-rate of 5.9 Gy/min was used to deliver the 
radiation dose. Other parts of the mice, especially bone marrow and 
testicles, were avoided by restricting the radiation field to 3x3 cm2 
with only the lower quadrant placed over the caudal-dorsal part of the 
mouse. A 5 mm thick tissue-equivalent bolus was used. The source-to-
skin distance was 100 cm, and approximately a total length of 1.5 cm 
of the distal colon was irradiated (Figure 1). After irradiation, mice 
were returned to the cages. Sham-irradiated mice were anesthetized but 
not subjected to radiation, and otherwise treated identically. For a pilot 
experiment, we developed a protocol based on small-field radiation to 
the juvenile mouse brain [74]. In the pilot experiment, we analyzed any 
changes in the histology of the colorectum after 2, 3 or 4 fractions of 6 
or 8 Gy with 12 hours interval. We found that the administration of 
four fractions of 8 Gy (32 Gy total) caused sustained morphological 
changes similar to that seen in biopsies of irradiated pelvic-organ 
cancer survivors [75]. This protocol was used in all later experiments. 
Comment: Our ability to study and design new therapies for the late 
(chronic) effects after irradiation are limited by a lack of proper animal 
models. In a typical model, the animals die one to two weeks after 
irradiation due to gastrointestinal or immune-system failure. This 
occurs when the ionizing irradiation cannot be restricted to a small 
field. In contrast, our mice had a normal life span and maintained a 
normal weight, despite receiving high doses of irradiation. This long 
survival is achieved by limiting target volume and avoiding damage to 
the immune or gastrointestinal system.  
We used a linear accelerator to produce our model. The linear 
accelerator is used as an external beam radiation treatment to treat 
cancer patients [1]. It delivers high-energy x-rays with a high dose rate 
to the cancer cells and limits the damage to surrounding tissue. By 
using a linear accelerator, we made our mouse model mimic as closely 
as possible pelvic radiotherapy, delivering a high dose of irradiation 
(clinically relevant), with a dose rate identical to that given to patients, 
and in several fractions. In our pilot studies, we found that crypt 
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degeneration was dependent on the number of fractions rather than the 
dose given [76], thus fractionation is an important factor when trying 
to produce intestinal pathophysiology similar to that seen after pelvic 
radiotherapy. 
A. Linear accelerator 
 
Figure 1. A. Varian linear accelerator. Courtesy of Varian Medical Systems 
Inc. B and C. The mouse was anesthetized with an anesthesia mask and 
placed in silicone mold and the body was covered with a 5 mm thick bolus. 
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Sacrifice and sample collection 
At the chosen time points after irradiation (indicated in each paper as 
Figure 1A), animals were deeply anesthetized with isoflurane. The 
abdomen was opened and blood was drawn by cardiac puncture of the 
left ventricle with the syringe. The intestine was flushed with ice-cold 
PBS and a thin, soft silicone tubing was inserted. 7 mm of the distal 
colon was carefully excised and placed immediately in 4% PFA (I & II 
paper) or methacarn (III & IV paper) overnight before dehydration and 
embedding into paraffin blocks.  
Serial sectioning procedure 
Paraffin blocks were cut into 4-μm thin sections on a microtome (Leica 
RM2235; Leica Biosystems) to study histological changes. The 
sections were mounted serially so that each sixth section was 
positioned on the same slide (1:6 series). Therefore each section was 
separated from the other sections on the same slide by at least 20 μm, 
which prevented the person from analyzing the sections from 
analyzing the same crypt twice. 
Comment: We used thin silicone tubing while harvesting the tissue. 
That preserved the shape of the colon and minimized variables such as 
stretching, and increased the chance of getting transversally sectioned 
crypts.  
Transverse sectioning made it possible to count crypts per 
circumference instead of mm mucosa, which can be affected by many 
factors, such as stretching or shrinking. That is also what made it 
possible to use stereology-based methods to quantify macrophages.  
Assay of radiation-induced damage-acute apoptosis 
Colorectal tissue was harvested 4.5 h after the last radiation dose, 
frozen on dry ice and stored at -80°C. After being thawed, tissue was 
cut into small pieces and placed in 0.7 ml of ice-cold homogenization 
buffer. Then the homogenate samples were sonicated on ice and 
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centrifuged for 10 mins at 10, 000 g. The resultant supernatant was 
used to measure protein content by Bradford assay. 
The DEVDase assay was performed using 20 μl of the supernatant 
obtained as described above and mixed with 80 μl of extraction buffer. 
This solution was pre-incubated for 15 min at room temperature before 
the addition of 100 μl of peptide substrate and 25 m caspase substrate 
(Ac-Asp-Glu-Val-Asp-aminomethyl coumarin) in an assay buffer. The 
cleavage of the substrate was measured at 37°C using a SpectraMax 
Gemini microplate fluorometer with an excitation wavelength of 380 
nm and an emission wavelength of 460 nm. The degradation was 
followed at 2-min intervals for two hours, and maximal velocity was 
calculated from the entire linear part of the curve. Standard curves with 
7-amino-4-methyl coumarin in the appropriate buffer was used to 
express the data in picomoles of AMC formed per minute per 
milligram of protein. 
Human biopsies 
Human biopsies were collected from patients who had received 
radiotherapy and also had undergone surgery. The biopsies were taken 
during surgery, approximately 10 cm from the tumor. Nineteen 
biopsies were acquired 3-5 days after completion of radiotherapy from 
patients who had received 25 Gy in five fractions (5 Gy x 5).  Another 
thirteen biopsies were obtained 6-11 weeks after completion of 
radiotherapy from patients who had received 45-50 Gy in 25 fractions 
(1.8-2 Gy x 25). Biopsies from 13 rectal cancer patients who had not 
received radiotherapy were also retrieved. Collected biopsies were 
fixed in paraformaldehyde before embedding in paraffin, and these 
paraffin blocks were cut on a microtome in 6 µm-thin sections. 
Informed written consent was obtained from the patients. The ethical 
committee of the University of Gothenburg approved this study (EPN 
118-15). 
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Immunohistochemistry (IHC) 
The tissues in the studies for this thesis were fixed in different ways 
prior to IHC: In those for papers I & II, colorectal tissue was fixed in 
paraformaldehyde and for paper III, colorectal tissue was fixed in 
methacarn, before embedding in paraffin. After deparaffinization at 
60°C, all the slides were rehydrated through xylene and graded washes 
of ethanol. For Ki-67, CD-31, and Iba1 staining different antigen 
retrieval was performed. Endogenous peroxidase activity was blocked 
for 10 minutes using a 0.6% peroxidase blocking solution. For BrdU 
staining, the tissue was pre-heated with 2 N HCl followed by borate 
buffer. Slides were washed in TBS and incubated with a blocking 
solution containing 3% normal donkey serum and Triton in TBS for 30 
minutes at room temperature to reduce nonspecific immunostaining. 
After the blocking, slides were incubated with primary antibodies at 
4°C overnight. Then slides were washed and incubated with secondary 
antibodies for one hour at room temperature followed by washes in 
TBS and 2-5 minutes incubation in DAB solution. Slides were 
dehydrated with graded ethanol and xylene washes, mounted with 
Xtrakitt and coverslipped. 
Primary antibodies  
Antibody Dilutions & Company Detecting 
anti-rabbit Ki-67 1:150 MerckMillipore Cell proliferation 
anti-mouse BrdU 1:500  DAKO Cell survival 
goat anti-CD31 1:150  R&D systems Blood vessels 
anti-rabbit Iba1 1:2000 Wako chemicals Macrophages 
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Secondary antibodies 
Antibody Dilutions & Company 
Biotinylated 1:250, Vector laboratories 
Donkey-anti-rabbit 1:250, Jackson laboratories 
 
Comment: Immunohistochemistry (IHC) is a method in which a target 
protein (antigen) is detected visually by binding with antibody 
(immunolabelling). The antigen retrieval process exposes the epitope 
to an antibody. This process is dependent on the antigen, the type of 
fixation used for the tissue and also the primary antibody used. In 
paper I and II, citrate buffer and in the study for paper III Tris-EDTA 
was used for antigen retrieval method. 
Quantification of cell proliferation and cell survival 
Crypt cell proliferation and cell survival were quantified by using a 
Leica DMi6000 microscope equipped with a semi-automated 
stereology system. In each section, well-oriented crypts, where the 
maximum of the crypt axis was visible, were included to quantify cell 
proliferation and survival. In total per animal, 24 crypts in two sections 
that were separated by 72 μm were analyzed.  
Comment: Ki-67 is used as a marker for cell proliferation and 
expressed throughout the cell cycle except for the G0 phase. 
Bromodeoxyuridine (BrdU) is a nucleoside analog, which incorporates 
into DNA during the process of DNA replication by replacing 
thymidine. BrdU has a short half-life, which means that cells that were 
dividing at the time of injection will incorporate it into their DNA, and 
the cell can be followed until it is shed into the lumen.  Mice were 
injected intraperitoneally with BrdU 4 days before the sacrifice 
because the mucosa is being replaced within a week. 
 
Dilip kumar Malipatlolla 
 
17 
Quantification of macrophages 
To quantify the number of macrophages in the colonic mucosa, 
sections were incubated with an antibody against ionized calcium-
binding adapter molecule 1 (Iba1). In the studies for papers I and II, 
with a Leica DM6000B microscope equipped with a semi-automated 
stereology system; we systematically placed a virtual frame at four 
different places 0°, 90°, 180° and 270°. Then we traced the mucosal 
area in between the crypts. All the Iba1+ cells within the traced area 
were counted. In the study for paper III, we used a stereology-based 
approach: the entire mucosal area per circumference was traced with 
5x magnification and Iba1+ cells were counted with 40x magnification. 
A grid was placed over the traced area and counting frames were 
placed at each intersection. Around 50 counting frames/section were 
analyzed for the number of Iba1+ cells. Based on the number of cells 
counted, the Stereo Investigator software estimated the total number of 
cells present in the traced area.  
Assessment of blood vessels 
Sections incubated with an antibody against CD31 were used to assess 
the number of blood vessels in the mucosa and submucosa of the 
colon. Two sections per animal, which were separated by 72 μm, were 
analyzed. 
Histochemistry 
For visualizing crypts, degenerating crypts and crypt fission either 
Alcian Blue combined with Nuclear Fast Red or Verhoeff’s elastic 
stain was used.  Briefly, slides were deparaffinized and rehydrated 
with descending grades of alcohol. After rehydration, slides were 
treated with acetic acid for 3 min and followed by Alcian Blue (pH 
2.5) for 30 min. Then slides were rinsed with water and counterstained 
with Nuclear Fast Red for 5 min. In the case of Verhoeff’s elastic stain, 
the same protocol followed until the rehydration step, after rehydration 
slides were stained according to a standard protocol. 
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Assessment of degenerating crypts, crypt fission, and 
surviving crypts 
Alcian blue/Neutral Fast Red or Verhoeff’s elastic stain stained 
sections were used to quantify the number of degenerating crypts and 
crypt fission. A total of six sections per animal, separated by 24 μm, 
were analyzed at 40X magnification.  
For the quantification of surviving crypts in the colon, three sections 
per animal, separated by 48 μm, were counted, and the average number 
was calculated. 
Serum cytokine and chemokines analysis by Luminex 
Bead-Based Multiple Assay  
A Bio-plex Mouse Cytokine 23-plex (Bio-Rad Laboratories AB, 
Solna, Sweden) was used to measure the concentration of cytokine and 
chemokines in the serum. The assay plate was pre-wet with a wash 
buffer initially and then primed with a bead solution. After that, 
samples and standards were added to the plate containing bead solution 
and incubated. After washing with a wash buffer, the plate was 
incubated with the detection antibody followed by streptavidin-PE 
incubation. Then the plate was re-washed, and the beads were re-
suspended with assay buffer. The fluorescence intensity was measured 
using the Bio-Plex 200 system. The data were processed using the Bio-
Plex Manager Software. The concentration of serum cytokines and 
chemokines was expressed in pg/ml. 
Statistical analysis  
Statistical analysis was performed using the GraphPad Prism software. 
Data in the papers were presented as the mean + standard error of the 
mean (S.E.M). A P-value equal to or below 0.05 when comparing 
groups was considered statistically significant. 
 In Paper 1, we used a one-way analysis of variance (ANOVA) 
followed by Dunnett’s test for normally distributed data. When data 
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was not normally distributed, a nonparametric Kruskal-Wallis test 
followed by Dunn’s multiple-comparison was performed. In Paper II, 
an analysis of the comparison was done by a Student’s t-test. In Papers 
III and IV, Student’s t-test was used for normally distributed data. 
Mann-Whitney test was performed for non-normally distributed data.  
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MAIN RESULTS AND DISCUSSION 
Paper I  
To increase our chances of preventing radiation-induced late effects in 
the intestines, some important questions need to be answered. Some 
examples of such questions are: When do late symptoms arise after 
pelvic irradiation, and for how long? How long does inflammation 
persist? What role does inflammation play in the progression of the 
radiation-induced disease? What are the repair mechanisms that are 
activated after radiotherapy? What factors, life-style related or other, 
influence the repair or progression of radiation-induced intestinal 
injury? 
These questions are, in part, difficult to answer because of a lack of 
suitable animal models that allow for long-term follow up after high-
dose irradiation. Most of the current mouse models rely upon whole-
body irradiation, which results in reduced survival rate due to 
gastrointestinal failure or the collapse of the immune system. To be 
able to understand radiation-induced late effects of the intestines, and 
to develop successful strategies to combat them, better preclinical 
models are needed. A model where it is possible to give relevant doses, 
with minimal off-target effects and preserved survival that allows for 
long-term follow-up, is desirable. In paper I, we used the clinic’s linear 
accelerators to make a model that would fulfill these criteria.  
Radiation-induced acute apoptosis in the colorectum 
As described in the method part, only the colorectum was irradiated 
using small-field irradiation. To verify the correct placement of the 
irradiation field and the restriction of the radiation field to the distal 
bowel, we measured the acute apoptosis in the non-irradiated proximal 
colon and the irradiated colorectum of sham-irradiated mice, and mice 
irradiated with 2 and 4 fractions of 6 Gy. We observed a statistically 
significant acute cell death in the colorectum of mice irradiated with 2 
fractions of 6 Gy but not in mice irradiated with 4 fractions of 6 Gy.  
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Figure 2. Irradiation-induced acute apoptosis in the colorectum and proximal 
colon. A statistically significant difference was seen in colorectum compared 
to sham-irradiated. This figure is taken from Bull et al. Am J Physiol 
Gastrointest liver physiol. 2017 Nov 1; 313(5): G456-G466. 
There was no statistically significant acute apoptosis in the proximal 
colon between sham–irradiated and irradiated animals, confirming a 
minimal spread of radiation outside the boundaries of the radiation 
field. That we did not see acute apoptosis in the colon after four 
fractions of 6 Gy, could be explained by the findings by Potten and 
colleagues, showing that maximum apoptosis of the actively dividing 
stem cells in the crypt at the moment of irradiation is achieved already 
at one fraction of 6 Gy. By the time the fourth fraction was given, the 
pool of stem cells sensitive to apoptosis might have been depleted. 
Survival of the mice over time after pelvic irradiation 
There was no overt weight loss observed in mice irradiated with 2, 3, 
and 4 fractions of 6 Gy or 2 fractions of 8 Gy compared to sham-
irradiated mice. However, mice irradiated with 3 or 4 fractions of 8 Gy 
fractions had a slightly decreased body weight compared to sham-
irradiated at 2, 3, and 4 weeks after irradiation. By 6 weeks after 
irradiation, the differences in body weight were no longer significant. 
Radiation-induced acute apoptosis (4.5 hours)
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Figure 3. A: the 6-Gy groups maintained a normal weight curve throughout 
the study. B: at 2, 3, and 4 weeks after irradiation, there was a small but 
significant decrease in weight in the 8 Gy x 3 and 8 Gy x 4 groups. Bull et al. 
Am J Physiol Gastrointest liver physiol. 2017 Nov 1; 313(5): G456-G466.  
Our mice received a total of either 24 Gy or 32 Gy of radiation and 
were followed for six weeks. Studies performed by others have shown 
that mice exposed to 8-20 Gy of total body irradiation, succumb due to 
bone marrow damage [32, 77, 78]. In one study, the survival time of 
mice after total-body irradiation was drastically reduced when the 
radiation dose increased above 14 Gy [31]. The main reason for the 
survival of the mice in our studies was the small irradiation field that 
prevented damage to the other parts of the body.  
Radiation-induced crypt loss 
Mice irradiated with 2 or 3 fractions of 6 Gy did not show crypt loss. A 
statistically significant loss was only seen in mice irradiated with 4 
fractions of 6 Gy compared to sham-irradiated mice. However, when 
using 6 Gy fractions, we did not induce enough tissue damage to 
produce a profound effect. Therefore, we increased the dose to 8 Gy 
per fraction, where we found similar morphological damage to what is 
seen in biopsies from cancer patients having undergone pelvic 
radiotherapy (Paper II, Figure 1g).  
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In a similar manner, we found extensive crypt degeneration only at the 
fourth fraction, regardless of whether 6 Gy or 8 Gy was given [76]. 
Thus, although 3 x 8 Gy is the same total dose as 4 x 6 Gy (24 Gy), 
and 3 x 8 Gy is a higher biologically effective dose, the fourth fraction 
was required to induce the desired effect. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. A. A decrease in crypt numbers (reflecting crypt loss) was evident 
first at the fourth fraction in mice irradiated with 4 fractions of 6 Gy or 8 Gy. 
B and C. Representative microscopic images of sham-irradiated and 
irradiated mice colorectal mucosa stained with Alcian Blue/Nuclear Fast Red. 
Bull et al. Am J Physiol Gastrointest liver physiol. 2017 Nov 1; 313(5): 
G456-G466.       
Our results suggest a threshold for crypt degeneration and crypt loss 
that is dependent on the number of fractions delivered during 
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irradiation. Potten reported that one surviving stem cell is capable of 
repopulating and rescuing the crypt [79].  One explanation for our 
results may be that the fourth fraction eliminated the last reserve stem 
cell in many of the crypts, leading to crypt degeneration. Another 
explanation may be that irradiation causes damage to the blood vessels 
resulting in reduced blood flow leading to hypoxia. Hypoxia, in turn, 
triggers ischemia, ultimately leading to crypt death. Studies have 
suggested that vascular injury is a primary source of damage from 
unwanted irradiation and thereby included in the pathways leading to 
radiation-induced crypt stem cell death. We also observed an increase 
in the number of macrophages in the gut mucosa at the fourth fraction 
indicating the inflammatory activity. Inflammatory activity is a strong 
modulator of stem cell activity and health [80].  
Although a fourth fraction was required to induce crypt loss at 6 weeks 
post-irradiation, we also observed that 8 Gy induced a more profound 
crypt loss than 6 Gy. Our data and other data support the notion that 
crypt degeneration is dependent on the total dose delivered to the 
animals [81, 82]. 
In conclusion, our mouse model is well suited for studying underlying 
pathophysiological processes in the intestines after radiation, 
especially concerning long-term effects and the importance of 
fractionation. The placement of the radiation field over the colorectum 
mimics treatment regiments for rectal, anal, urinary and gynecological 
cancers, where the sigmoid colon and rectum receive the highest 
radiation dose. Furthermore, the distal placement also makes the model 
well suited for trying especially topical interventions. 
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Paper II 
A comprehensive understanding of the gross injury and repair 
dynamics after pelvic radiotherapy would aid in the deciphering of 
their underlying mechanisms. We performed successive short and 
long-term experiments where the progression of crypt degeneration, 
inflammatory activity, crypt-cell proliferation, and cell survival was 
determined at different time points after irradiation. The time points 
evaluated were 24 hours (acute), one week (early), 6 weeks 
(intermediate), 18 weeks (late) and 30 weeks (chronic).  
Long-term survival of the mice after pelvic radiation 
All the mice that received four fractions of 8 Gy survived and 
displayed a normal weight curve. At 30 weeks, irradiated mice had a 
non-significant increase in body weight compared to sham-irradiated 
mice. 
 
 
 
 
 
 
 
 
 
 
Figure 5. Weight graph (in grams) for the 30-week group. Sham-irradiated 
and irradiated mice gained weight in similar manner. Malipatlolla et al.  Sci 
Rep. 2019; 9: 13803. 
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Irradiation-induced crypt-loss mucosal damage 
 Degenerating crypts were never observed in the sham-irradiated mice. 
However, the irradiated mice displayed crypt degeneration at all the 
time points, peaking at one week (Figure 6). This was reflected in a 
statistically significant crypt loss at all time points except at 24 hours 
and 1 week post-irradiation. Thus, crypt loss lagged somewhat behind 
the peak of crypt degeneration. This is possibly a reason why we were 
unable to find a correlation between the number of degenerating crypts 
and surviving crypts at the given time points (data not shown). 
 
 
 
 
 
 
 
Figure 6. Number of degenerating crypts over time. Degenerating crypts 
were found at all time points studied, peaking at 1 week. Crypt degeneration 
did not occur in sham-irradiated mice. Malipatlolla et al.  Sci Rep. 2019; 9: 
13803. 
Following exposure to ionizing radiation, crypt stem cells undergo 
apoptosis due to their rapid proliferation activity, which makes them 
more sensitive to radiation [82]. This may lead to crypt degeneration. 
A study by Potten showed that the crypt cell apoptosis peaked around 
4 hours after post-irradiation [13].  In contrast, our results showed very 
few degenerating crypts at 24 hours after the last fraction, suggesting 
that crypt degeneration is a slower process. Our quantification of 
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surviving crypts also revealed that the crypt loss most likely was 
permanent after 4x8 Gy, since the crypt density in the irradiated 
mucosa never recovered.  
Radiation-induced angiogenesis 
We quantified the number of CD31 positive blood vessels at various 
time points after irradiation. No difference in number was observed 
between irradiated and sham-irradiated at 24h, 6w, and 18 weeks post-
irradiation.   
 
 
 
 
 
 
Figure 7. Percentage change in number of blood vessels compared to sham-
irradiated over time after irradiation. This figure was taken from Malipatlolla 
et al. Sci Rep. 2019; 9: 13803. 
At 1 week, there was a decrease in the number of blood vessels 
between irradiated and sham-irradiated mice. In contrast, an increase in 
the number of mucosal blood vessels was observed in irradiated mice 
compared to sham-irradiated mice at 30 weeks (Figure 7). 
Along with crypt stem cell death, vascular damage plays a vital role in 
the development of acute and chronic effects in the intestines after 
radiotherapy [83]. Several studies propose that damage to the blood 
vessels is the primary injury after irradiation [31, 84].  Similar to the 
trajectory of crypt degeneration, loss of blood vessels was seen first at 
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one week post-irradiation. One study of rectal biopsies taken from 
cancer patients, four months after pelvic radiotherapy showed severe 
vascular changes associated with crypt distortion and severe fibrosis of 
lamina propria [85]. A study by Okunieff showed that mice treated 
with angiogenic growth factors had more surviving crypts in the 
intestines after irradiation [86]. This indicates an important role of 
blood vessels in crypt survival.  
Inflammatory activity 
In this study, we followed up our previous results of infiltrating 
macrophages indicating a low-grade inflammation at six weeks, by 
quantifying the number of macrophages at 24h, 1w, 6w, 18w, and 30 
weeks post-irradiation. Irradiated mice did not show signs of 
macrophage infiltration in the mucosa at 24 hours and only a slight 
increase in infiltration of macrophages was seen at 1 week but this was 
not statistically significant. We found that the higher abundance of 
infiltrating macrophages at 6 weeks lasted throughout 18 weeks and 30 
weeks post-irradiation (Figure 8). 
This late-occurring and long-lasting increase in the density of mucosal 
macrophages could reflect a chronic low-grade inflammation after 
irradiation. Recent studies have confirmed the infiltration of 
macrophages within the site of injury after irradiation [87, 88]. A study 
by Ibuki showed that high doses of irradiation stimulate the activation 
of macrophages, which are crucial mediators in the inflammation 
process [89]. We observed inflation of the macrophages in areas where 
“gut leakiness” might be suspected, such as right above the 
degenerating crypts (Figure 8E) suggesting that a leakiness of the 
epithelial barrier attracts the macrophages to the site of injury [90, 91]. 
Similar to the increase in the number of mucosal macrophages, a 
significant decrease in the number of the surviving crypt was seen at 
6w, 18w and 30 weeks post-irradiation. Previous studies have 
confirmed that loss of crypts can lead to the breakdown of the 
intestinal epithelial barrier and also mucosal damage [79, 92] 
Dilip kumar Malipatlolla 
 
29 
A. Radiation-induced infiltration of macrophages in the mucosa 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Radiation induced mucosal macrophage infiltration. A statistically 
significant increase was seen at 6, 18 and 30 weeks post-irradiation. 
Malipatlolla et al. Sci Rep. 2019; 9: 13803. 
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Crypt fission- a repair mechanism 
Crypt fission, which is a natural phenomenon of colonic growth and a 
repair mechanism after injury, was observed more frequently in 
irradiated animals than in sham-irradiated. It was dependent on dose 
and/or fraction since mice irradiated with 4 fractions of 8 Gy displayed 
more crypt fissions than mice irradiated with 2 or 3 fractions of 8 Gy 
(Figure 9 A).  
At 24 hours post-irradiation, there was a slight but non-significant 
increase in crypt fission that became more obvious in one week. By six 
weeks, all irradiated mice displayed crypt fission in the analyzed 
tissue.  At 18 weeks, the peak of fissions subsided and was back to 
control levels at 30 weeks post-irradiation (Figure 9 B).  
 
 
 
 
 
 
 
 
Figure 9. A. Crypt fission showing damage-dependent response. B. Crypt 
fission over time. Irradiated mice had a greater number of crypt fissions than 
did sham-irradiated at 6 weeks. Malipatlolla et al. Sci Rep. 2019; 9: 13803. 
We observed what appeared to be a very small increase in the number 
of proliferating cells at 6, 18 and 30 weeks post-irradiation, but this 
was not statistically significant (Paper II, Figure 4a). 
After the initial injury, a mucosal repair can occur through two 
different mechanisms; crypt cell proliferation and crypt fission. 
Previous studies demonstrated the role of crypt fission in colonic 
growth and repair [54, 93]. Our data indicate an important finding; that 
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it is crypt fission, not cell proliferation that repairs the damaged tissue 
in the long-term. Most studies have focused on cell proliferation, thus 
possibly missing an important repair mechanism. Crypt fission is 
known to be able to occur without signs of increased cell proliferation 
[94]. Our results are supported by a study where irradiated mice 
showed an increase in crypt fission compared to control mice [95].  
In conclusion, our results suggest that the irradiation of the colorectum 
causes permanent loss of crypts, eventually replaced by fibrotic tissue, 
and also increases in the infiltration of mucosal macrophages over time 
indicating persistent intestinal inflammation. If this can be confirmed 
in survivors who underwent pelvic radiotherapy, a successful approach 
to restoring intestinal health in these patients could take into account 
the ongoing low-grade intestinal inflammation. Additionally, we 
suggest that crypt fission is a more important long-term repair 
mechanism after irradiation than crypt cell proliferation. Since crypt 
fission was seen at all the time points after the initial injury, the 
therapeutic window of opportunity for the mucosal healing after 
radiotherapy may be much wider than what has been previously 
estimated. Further studies are needed to explain how crypt fission is 
regulated and why it fails to repair mucosal damage completely. 
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Paper III 
A recent dietary intervention study performed by Wedlake and 
colleagues revealed that pelvic cancer survivors that consumed a diet 
rich in fiber had reduced gastrointestinal toxicity compared to cancer 
survivors with a habitual-fiber intake [96]. Despite the increasing 
number of reports on the beneficial effects of fiber in conditions such 
as irritable bowel syndrome and inflammatory bowel disease [97, 98], 
pelvic cancer patients are still commonly advised to consume a low or 
no-fiber diet during pelvic radiotherapy [99]. In the study leading to 
Paper III, we extended our knowledge reported in Paper II to 
investigate the hypothesis that a diet high in fiber increases the 
resiliency of the gut wall and protects against radiation-induced 
intestinal damage. 
Mice were fed either with a diet rich in fiber from bioprocessed oat 
bran (“high-oat”) or a fiber-free (“no-fiber”) diet. The dietary 
intervention started two weeks before irradiation and was maintained 
for 1, 6, and 18 weeks after irradiation. The colorectal tissue was 
collected at the different time points and analyzed for the occurrence of 
degenerated crypts, the number of surviving crypts, crypt fission, crypt 
cell proliferation, and mucosal infiltration of macrophages.  
We found that mice on the no-fiber diet had more degenerating crypts 
at one week after irradiation than mice on the high-oat diet. We also 
observed that the fiber-deprived irradiated mice had fewer surviving 
crypts at the short (1 week) and intermediate (6 weeks) time points 
(Paper III Figure 4). There are other studies pointing in the same 
direction; rodents fed with a fiber-free diet had fewer surviving crypts 
compared to rodents on a fiber-rich diet after irradiation [100, 101].  
However, our follow-up at 18 weeks post-irradiation revealed that the 
high-oat diet was not able to rescue the crypts in the long run. This 
highlighted the progressive and long-lasting effects of radiation on 
intestinal health, and that conclusions based on short-term follow-up 
might be misleading. It is plausible that the initial DNA damage 
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caused by the ionizing irradiation will eventually deplete the stem cells 
in the crypts, regardless of measures taken to improve the 
microenvironment. Nevertheless, the course of the disease can be 
delayed, which may have important clinical implications.  
As mentioned before, radiation to the intestine is believed to increase 
the permeability of the intestinal wall to pathogens. One mechanism 
causing a delay of crypt loss could be that fiber-rich diets prevent the 
entry of pathogens into the colonic tract by enhancing the formation of 
a thicker protective inner mucus layer [102]. The dietary fibers 
undergo degradation in the colon by fiber-degrading bacteria, 
producing energy that is used to form the mucus, which prevents the 
entry of a pathogen [103]. This could reduce inflammation, which is 
known to be deleterious to especially stem cells. Another aspect is that 
a diet deprived of fiber starves the colonocytes, which are dependent 
on fiber-derived butyrate as their main source of energy [72, 104, 105].  
It is reasonable to believe that the starved colon becomes more 
susceptible to irradiation-induced pathophysiological processes since 
repair processes such as crypt fission or cell proliferation would 
require extra energy.  
A statistically significant increase in crypt cell proliferation was seen 
in high-oat irradiated mice compared to no-fiber irradiated mice (Paper 
III Figures 3 and 5). As explained earlier, crypt cell proliferation and 
crypt fission are the two main repair mechanisms that play a vital role 
in the regeneration of crypts after damage. Sureban et al. found that 
soluble dietary pectin increased cell proliferation in the crypts after 
irradiation [101]. The mechanism by which diet rich in fiber increases 
crypt cell proliferation is suggested to be the breakdown of fiber into 
short-chain fatty acids in the colon to produce butyrate, acetate, and 
propionate, out of which butyrate serves as the main energy source for 
the colonocytes [60]. In our previous studies (Paper I and II), we did 
not see any changes in cell proliferation after irradiation, leading us to 
believe that repair was executed via crypt fission, not cell proliferation. 
The mice in that study consumed standard chow, consisting of a nearly 
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the same amount of dietary fiber as the high-oat diet (13% vs 15%, 
respectively), but having a high fraction of insoluble fiber (85%) with 
low levels of -glucan (0.6% vs 28%, respectively). The very high 
amounts of -glucan in the current study could explain the 
discrepancies in our findings concerning cell proliferation after 
irradiation. -glucan efficiently produce butyrate, induce proliferation, 
and stimulate the immune system, and possibly, the butyrate 
production allowed the proliferative response to last longer in our 
high-oat mice [106, 107]. However, it cannot explain why the no-fiber 
mice also responded to irradiation with cell proliferation at one week, 
while animals on standard chow only had a slight but insignificant 
increase at 6 weeks and onwards. An explanation for this can be that 
every fiber-composition causes a different time peak of proliferation 
and that in the study for Paper II, we missed the proliferation response 
of animals fed standard chow at 1, 6, and 18 weeks. Alternatively, the 
composition of the standard chow does not allow for a proliferative 
response, for an unknown reason.  After all, animals fed standard chow 
lost as many crypts as the no fiber at the one week after irradiation, 
which supports the notion that it was the composition of the 
bioprocessed oat bran that was especially important in determining 
what took place. 
Crypt fission, a growth and repair mechanism that has largely been 
overlooked could be responsible for the increase in the number of 
crypts both in the sham-irradiated and irradiated high-oat mice. We 
observed that mice fed with high-oat diet appeared to have more 
intense crypt fission early on compared to the no-fiber mice but the 
underlying mechanism is unknown.  
In conclusion, a diet rich in fiber modified the onset, timing, and 
intensity of intestinal pathophysiological processes and repair 
mechanisms after radiation. This does not mean that we now know 
what dietary advice to give to pelvic cancer patients. For example, we 
do not know how various types of fiber modulate the outcome, and 
diets rich in fiber normally also contain other compounds such as 
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polyphenols that could influence bowel health. In addition, despite 
being able to stimulate cell proliferation and crypt fission we were not 
able to rescue the crypts; this may have unknown implications for 
bowel health. Nevertheless, further studies on the importance of the 
dietary fiber given before, during and after pelvic radiotherapy might 
give us a means other than reducing the radiation dose to protect the 
normal tissue in the cancer survivor. 
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Paper IV  
Radiation alters the gut homeostasis balance by activating both pro- 
and anti-inflammatory pathways [108, 109]. As mentioned before, 
radiation causes acute intestinal inflammation, where increased 
permeability of the intestinal epithelial barrier is believed to allow the 
bacteria to translocate into the lumen [16, 110]. The general perception 
is, however, that the inflammation quickly subsides when the intestine 
either repairs itself or becomes fibrotic [2]. Our data from the mouse 
model did not support this and in the study for paper IV, we set out to 
investigate whether the increased macrophage density is seen in Paper 
I-III reflected a persisting low-grade inflammation that could be 
modified by a diet rich in fiber.  
Cytokine and chemokines are important mediators involved in both 
acute and chronic inflammatory processes acting locally at the site of 
injury or systemically. We aimed to determine the systemic cytokine 
levels, reflecting possible inflammatory processes in the tissue, at the 
various time points after irradiation in the mice from the dietary fiber 
study presented in Paper III. Thus, at the time of sacrifice, the blood 
was harvested and serum samples were prepared. The samples were 
then analyzed with a Luminex Bead-Based Multiplex Assay. In this 
assay, the color-coded beads were used to measure the analytes in the 
sample.  
Our results indicate an increase in pro-inflammatory cytokine levels in 
both the irradiated groups fed with the high-oat or no-fiber diets 
compared to sham-irradiated mice fed with the high-oat or no-fiber 
diets at all the time points after irradiation. This supports our 
hypothesis that there is a long-lasting low-grade inflammation after 
irradiation (Paper IV, Figures 2, 4 and 6). At one week post-irradiation, 
a significant increase in levels of IL-1 was seen in the irradiated mice 
compared to sham-irradiated mice regardless of diet. A few studies in 
rodents have shown that the irradiation increased the levels of IL-1 in 
irradiated animals compared to controls 2 weeks after irradiation [111, 
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112]. IL-1 is a pro-inflammatory cytokine known to be released by 
activated macrophages, neutrophils, epithelial cells, and endothelial 
cells. Similarly, our unpublished data showed a significant increase in 
mucosal macrophages in high-oat diet irradiated mice compared to 
high-oat diet sham-irradiated at one week post-irradiation (Paper III 
Figure 6). 
At six weeks post-treatment, irradiated mice fed the no fiber diet had a 
statistically significant increase in G-CSF cytokine levels compared to 
the no fiber sham-irradiated mice. A study by Tanji et al. found 
increased levels of G-CSF in the serum during radiotherapy in prostate 
cancer patients [113]. G-CSF plays a role in both innate and adaptive 
immune pathways, modulating the activation of both macrophages and 
dendritic cells. Similarly, at six weeks post-irradiation the no-fiber diet 
irradiated mice had a significant increase in macrophages compared to 
the no-fiber diet sham-irradiated (Paper III Figure 6).  
At all the time points, the high-oat diet mice had reduced levels of the 
circulating pro-inflammatory cytokines in the serum compared to mice 
fed a no-fiber diet, indicating a protective role of a high-oat diet. 
Studies have shown that oat -glucan decreases the levels of pro-
inflammatory cytokines in the inflamed intestine [114, 115]. 
We also observed the up-regulation of the canonical pathways and 
biological functions in irradiated mice compared to sham-irradiated. 
Irradiated mice fed a high-oat diet down-regulated the canonical 
pathways, biological functions, and upstream regulators compared to 
irradiated mice fed a no-fiber diet (Paper IV figure S6, S7, S8).  
In conclusion, our results indicate that irradiation increased both acute 
and chronic inflammatory cytokines levels in the serum and consuming 
a high-oat diet reduced both acute and chronic systemic inflammation 
in these mice compared to mice on a fiber-free diet. 
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CONCLUSIONS 
Here I highlight the most important conclusions and new insights 
from my research for this thesis.  
1.  The employment of linear accelerators and a very small irradiation 
field resulted in preserved animal survival and overall health, despite 
the high dose given. The gross pathophysiological changes found in 
the irradiated colorectum were very similar to those found in the 
human intestine after pelvic radiotherapy. 
2.  Infiltration of macrophages in the mucosa was persistent over time, 
indicating a subtle inflammatory activity that might be life-long. 
Regeneration of damaged tissue occurred through crypt fission at one 
week after irradiation and persisted for many weeks.  
3.  A diet rich in fiber profoundly changed the onset, timing, and 
intensity of pathophysiological processes in the intestines after 
irradiation.  
4. A diet rich in fiber reduced the inflammatory-related serum-
cytokine levels, whereas a fiber-free diet worsened the inflammatory-
related serum-cytokine levels, both acutely and chronically.  
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FUTURE PERSPECTIVES 
Evaluation of mucosal biopsies from pelvic cancer 
survivors 
We are collecting biopsies from survivors who underwent pelvic 
radiotherapy two to 20 years earlier. The biopsies will be investigated 
for the occurrence of chronic, low-grade inflammation and other 
pathophysiological processes. 
Mucosal injury - repair via crypt fission 
Our studies showed that after irradiation, crypt fission as a long-term 
repair mechanism was favored over crypt cell proliferation. Two 
important goals to be pursued in the future are to try to learn how crypt 
fission is regulated and to determine if promoting crypt fission would 
promote healing after irradiation. 
Dietary interventions in pelvic cancer survivors 
We will be evaluating a possible beneficial effect of eating dietary 
fiber during and after pelvic radiotherapy. Patients will receive around 
21 grams of fiber/day two weeks before, during, and 6 weeks after 
pelvic radiotherapy. Blood and fecal samples will be collected before 
the start of pelvic radiotherapy, during, 5 weeks and 12 months after 
the pelvic radiotherapy. Blood samples will be analyzed for acute or 
chronic inflammatory cytokine levels, and fecal samples will be 
analyzed for any changes in microbial composition and inflammatory 
markers. 
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